Position on Animal TestingAlbemarle Corporation is committed to meeting its obligations domestically and internationally to test new compounds to ensure the safety, reliability and effectiveness of the production and market placement of our products. At present, testing on living animals is still a necessary part of the regulatory approval process for new and existing chemicals. While legally we are unable to replace all animal testing in the foreseeable future, we fully appreciate and share the public concern for animal welfare in research and in safety assessments of chemicals. We strongly support and apply the principle of the 3 Rs: to Replace, Reduce and Refine animal experiments.Specifically:
- Albemarle maintains, and continues to enhance, capabilities for tiered data development to replace, reduce or complement animal testing. This includes extensive literature research, computer modeling and in vitro assays.
- Albemarle does not have its own animal testing facilities and commissions tests only at facilities which are fully approved by regulatory authorities and that comply with all applicable laws, regulations and licensing requirements. We ensure that staff at these facilities are trained, competent and implement only humane animal care techniques.
- We are actively working towards the development, validation and adoption of alternatives to animal testing through our active participation in industrial and scientific consortia (CEFIC, ACC, ECETOC, etc.)
- Albemarle promotes the use of integrated testing strategies to establish data for use in regulatory submissions worldwide in order to minimize the need to repeat animal testing.
- We are committed to the welfare and ethical treatment of animals and will listen to and discuss the concerns of others who express their concerns in a reasonable and lawful manner.
Last Updated: 2/25/2016 3:29:10 PM